A multicenter, open-label study to evaluate the preliminary safety and efficacy of CC-5013 [lenalidomide] in the treatment of complex regional pain syndrome (CRPS)

Trial Profile

A multicenter, open-label study to evaluate the preliminary safety and efficacy of CC-5013 [lenalidomide] in the treatment of complex regional pain syndrome (CRPS)

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2008

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Complex regional pain syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2008 The expected completion date for this trial is now 1 Aug 2007.
    • 09 Jan 2007 Status change
    • 25 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top